In addition to molecular targeted therapy, immunotherapy, especially immune checkpoint inhibitors (such as anti-PD-1, PD-L1, LAG3, TIM3, Tregs and immunosuppressive factors released by Tregs such as TGF-β, etc.), are utilized for HCC treatment [18]. Here, CD274 is linked to hepatocellular carcinoma.